Role of selective neck dissection over anti-TB therapy in retreating patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20243681Keywords:
Anti-TB therapy, Neck dissection, Retreatment, Treatment failure, TuberculosisAbstract
Background: Tuberculous cervical lymphadenopathy (TCL) remains a significant public health challenge, particularly in developing countries. This study aimed to analyze the demographic characteristics, treatment responses, and management outcomes in patients with TCL, focusing on the effectiveness of standard anti-TB medication and the role of surgical interventions in non-responsive cases.
Methods: This retrospective comparative analysis was conducted at the Department of Otolaryngology, Dhaka Medical College Hospital, Bangladesh, from July 2019 to July 2023. The study included 189 patients diagnosed with TCL. Patients were categorized based on their response to standard anti-TB medication over a period of one year and the subsequent management strategies adopted for non-responsive or slow-responsive cases.
Results: The study predominantly involved younger individuals (71.43% aged 15-30 years) with a higher representation of females (68.25%). A significant majority (61.38%) reported symptoms for more than one month. After six months of treatment, 33.86% showed a response to medication, increasing to 46.56% after one year. However, 19.58% exhibited slow or no response. Among non-responsive or slow-responsive cases, 18.92% opted for neck dissection, while 59.46% eventually showed a complete response to medication. The incidence of TB relapse was 6.35%, with the majority occurring at the primary infection site.
Conclusions: The study underscores the effectiveness of standard anti-TB medication in most TCL cases, with surgery as a secondary option for specific non-responsive or complicated cases. These findings highlight the need for early detection and individualized treatment strategies, emphasizing medical management as the cornerstone of TB treatment, with surgical interventions reserved for select scenarios.
Metrics
References
World Health Organization. Global TB progress at risk. Available at: https://www.who.int/news/item/14-10-2020-who-global-tb-progress-at-risk. Accessed 05 December 2023.
World Health Organization. Regional Office for Africa. Tuberculosis (TB). Available at: https://www.afro.who.int/health-topics/tuberculosis-tb. Accessed 18 June 2023.
Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120(4):316-53.
Kimura Y, Shimada M, Kawashima M, Yamane A, Nagai H, Matsui H. Relapse of cervical tuberculous lymphadenitis immediately after completion of effective anti‐tuberculosis treatments. Respirol Case Rep. 2020;8(4):e00555.
Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47-55.
Gaikwad P, Samuel VM, Rupali P. Tb or not Tb: Paradoxical response and the role of selective lymphadenectomy in tuberculous cervical lymphadenitis. India J Appl Res. 2018;6(10).
Cheng LHH, Bothamley G, Douglas A. Neck dissection for tuberculous suppurative cervical lymphadenitis. Brit J Oral Maxillof Surg. 2007;45(7):e16.
Dheda K, Barry CE, Maartens G. Tuberculosis. The Lancet. 2016;387(10024):1211-26.
Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362(9387):887-99.
Lange C, Abubakar I, Alffenaar JWC, Bothamley G, Caminero JA, Carvalho ACC, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014;44(1):23-63.
Spinelli G, Mannelli G, Arcuri F, Venturini E, Chiappini E, Galli L. Surgical treatment for chronic cervical lymphadenitis in children. Experience from a tertiary care paediatric centre on non-tuberculous mycobacterial infections. Int J Pediatr Otorhinolaryngol. 2018;108:137-42.
Prasad R, Arthur LG. Cervical Lymphadenopathy. Fundam Pediatr Surg. 2010;213-9.
Asaduzzaman A, Uddin MK, Azad MA, Safi A, Haque WS. Evaluation of tubercular cervical lymphadenopathy: diagnostic and therapeutic utility. Bangl J Otorhinolaryngol. 2020;23(2):127-32.
Peddireddy V. Quality of life, psychological interventions and treatment outcome in tuberculosis patients: the Indian Scenario. Front Psychol. 2016;7:1664.
Dedefo MG, Sirata MT, Ejeta BM, Wakjira GB, Fekadu G, Labata BG. Treatment outcomes of tuberculosis retreatment case and its determinants in West Ethiopia. Open Respir Med J. 2019;13:58-64.
Kanjanopas K, Siripan N, Phoophitphong R. Tuberculous cervical lymphadenopathy and the role of surgical treatment. Southeast Asian J Trop Med Public Health. 2014;45(6):1419-24.
Laycock KM, Enane LA, Steenhoff AP. Tuberculosis in adolescents and young adults: emerging data on TB transmission and prevention among vulnerable young people. Trop Med Infect Dis. 2021;6(3):148.
Gebreegziabher SB, Bjune GA, Yimer SA. Total delay is associated with unfavorable treatment outcome among pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a prospective cohort study. PLOS ONE. 2016;11(7):e0159579.
Nkosi D, Janssen S, Padanilam X, Louw R, Menezes CN, Grobusch MP. Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study. BMC Heal Serv Res. 2013;13(1):268.
Guo B, Liu W, Shao B. Radical neck dissection in treating cervical lymph node tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 1998;21(6):352-4.